Allspring Global Investments
CANO

Allspring Global Investments’s Cano Health, Inc. CANO Stock Holding History

Allspring Global Investments’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-858
Closed -$5.04K – 2456
2023
Q4 		$5.04K Buy
858
+534
+165% +$6.32K ﹤0.01% 2058
2023
Q3 		$8.2K Buy
324
+291
+882% +$23.9K ﹤0.01% 2631
2023
Q2 		$4.57K Sell
33
-86
-72% -$11K ﹤0.01% 2592
2023
Q1 		$10.9K Hold
119
– – ﹤0.01% 2588
2022
Q4 		$16.3K Sell
119
-3
-2% -$1.02K ﹤0.01% 2630
2022
Q3 		$105K Buy
+122
New +$76.5K ﹤0.01% 2069

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $844M AUM 37.96% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Allspring Global Investments's CANO Position: Q1 2024 in Review

Allspring Global Investments sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 858 shares — an estimated $5.04K sold.

Allspring Global Investments first reported a position in CANO in Q3 2022 and held it in 6 quarters. The position peaked at $105K in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • Allspring Global Investments reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 858 Cano Health, Inc. shares in Q1 2024, an estimated $5.04K.
  • Allspring Global Investments first reported a position in Cano Health, Inc. in Q3 2022 and held it in 6 quarters.
  • Allspring Global Investments's Cano Health, Inc. position peaked at $105K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.